Asian Spectator

ACN Newswire Business

Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad, a Treatment for Hyperuricemia and Gout, in China

  • Written by ACN Newswire - Press Releases

Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad, a Treatment for Hyperuricemia and Gout, in China

TOKYO, Feb 25, 2020 - (JCN Newswire) - Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment for hyperuricemia and gout discovered by FUJI YAKUHIN, for development and distribution in China.

Based on this agreement, Eisai will acquire exclusive development and marketing rights for dotinurad in China from FUJI YAKUHIN. FUJI YAKUHIN will retain responsibility for manufacturing the formulation of dotinurad, and supply to Eisai. Eisai will be responsible for a New Drug Application for dotinurad in China and pay FUJI YAKUHIN upfront payment, development milestone and sales milestone.

Hyperuricemia is the second most common metabolic disease after diabetes mellitus in China. In addition, hyperuricemia is known to be associated with various diseases in the urinary system, endocrine system, metabolic system, cardio-cerebrovascular system etc., including gout.

Furthermore, it is estimated that currently in China, the number of patients with hyperuricemia is approximately 190 million and the number of patients with gout is approximately 16 million.(1) It is expected that the number of patients will further increase in the near future due to changes in lifestyle and dietary preferences in accordance with socio-economic development in China.

Dotinurad is a new therapeutic agent for gout and hyperuricemia discovered by FUJI YAKUHIN. Dotinurad suppresses uric acid reabsorption and lowers blood uric acid levels, by selectively inhibiting the urate transporter (URAT1) related to reabsorption of uric acid in the kidney.

Under this agreement, Eisai will proceed with the development of dotinurad in China. Following commercialization, Eisai will aim to contribute to patients with hyperuricemia that are unmet medical needs by utilizing the knowledge and networks that Eisai has cultivated through its China business. FUJI YAKUHIN anticipates maximizing the value of dotinurad in China by leveraging Eisai's business base as the first step in the global expansion of dotinurad. Through the development and commercialization of dotinurad, Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in China and contribute to improving the quality of life of patients.

About Eisai Co., Ltd.

Eisai Co., Ltd. defines our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products to address unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.

As a global pharmaceutical company, our mission extends to patients around the world through working with key stakeholders to improve access to medicines in developing and emerging countries.

For further information on Eisai Co., Ltd., please visit https://www.eisai.com.

About FUJI YAKUHIN CO., LTD.

FUJI YAKUHIN CO., LTD. is a complex pharmaceutical company with an integrated manufacturing and sales system consisting of ethical drug sales, placement drug sales, drugstore business, and the pharmaceutical manufacturing business that supports them. Regarding ethical drugs, FUJI YAKUHIN has created two drugs with different mechanisms of action, topiroxostat and dotinurad, for gout and hyperuricemia.

For further information on FUJI YAKUHIN CO., LTD., please visit https://www.fujiyakuhin.co.jp/ (Japanese only)

About dotinurad

URAT1 and has a small effect on other transporters, so it reduces serum uric acid levels at lower doses. Dotinurad is expected to have a low risk of side effects and drug interaction.In Japan, on January 23, 2020, FUJI YAKUHIN CO., LTD. obtained manufacturing and marketing approval for dotinurad.

References:(1) For the estimated data regarding the number of patients with hyperuricemia as well as the number of patients with gout:- Dataofmorbidityprevalencerate-RuiLiuetal., PrevalenceofHyperuricemiaandGoutinMainlandChinafrom2000to2014: A Systematic Review and Meta-Analysis, BioMed Research International, Volume 2015, Article ID 762820- Estimated data calculated from United Nations World Population Estimates - World Population Prospects, URL: http://www.un.org/en/development/desa/population/

Contact:Eisai Co., Ltd.
Public Relations Department 
TEL: +81-(0)3-3817-5120

Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

St Kitts and Nevis Accepts Online Submissions for Citizenship ...

LONDON, March 30, 2020 /PRNewswire-AsiaNet/-- On 26 March, in light of the COVID-19 pandemic, the Federation of St Kitts and Nevis issued a Notice to Authorised Persons, Developers, Internat...

A Milestone for Next Century: Construction of Qingdao Internat...

QINGDAO, China, Mar. 29, 2020 /PRNewswire-AsiaNet/-- The Ground-Breaking and Global Business Promotion Ceremony of Qingdao International Cruise Terminal Area was held at Qingdao Port on Marc...

RavenPack Launches Free Coronavirus News Monitor to Help Data-...

NEW YORK, March 30, 2020 /PRNewswire-AsiaNet/ -- In response to the coronavirus pandemic, RavenPack, a leading provider of big data analytics, has launched a live and interactive website to ...

China Southern Selected Growth Balanced Fund Wins Morningstar Balanced Fund Award

BEIJING, Mar 28, 2020 - (ACN Newswire) - The Morningstar International Fund Awards are set to recognize the China 2020 winners on March 26. The China Southern Selected Growth Balanced Fund ...

Bosch Developing COVID-19-(SARS-CoV-2) Rapid Testing Kit for t...

WAIBLINGEN, Germany, Mar. 27, 2020 /PRNewswire-AsiaNet/-- Test delivers reliable results at the point of care in less than 2.5 hours - One of the world's first multiplex molecular diagnostic...

Empire State Building In Partnership With iHeartMedia's Z100 T...

NEW YORK, Mar. 28, 2020 /PRNewswire-AsiaNet -- Empire State Realty Trust, Inc. (NYSE: ESRT) and iHeartMedia (Nasdaq: IHRT) today announce their partnership to reach those sheltering at home...

Vestas secures fourth intertidal wind project and first 20-yea...

SINGAPORE, March 27, 2020 /PRNewswire-AsiaNet/ -- Maintaining its successful momentum with 200 MW order intake in Vietnam last year, Vestas has now secured its fourth intertidal project in t...

HotForex Makes Generous Donation to WHO Amid COVID-19 Crisis

PORT LOUIS, Mauritius, March 27, 2020 /PRNewswire-AsiaNet/ -- In line with its commitment to social responsibility, award winning broker HotForex has made a generous donation to the World He...

The "Poison" of Gaming Giants – Decentralized Anonymous Gamification Exchange DAGE

SINGAPORE - Media OutReach - 27 March 2020 - Negotiations are impossible when an industry is monopolized, with the disadvantaged majority having no power over the indu...

Nippon Express's Chuo International Office (Osaka) Acquires Ha...

TOKYO, Mar. 27, 2020 /Kyodo JBN-AsiaNet/ -- - Halal Network Expanded to Third Location in Japan -Nippon Express Co., Ltd., on Wednesday, March 4, received halal certification from the Japan ...

Tai Hing Announces 2019 Annual Results

HONG KONG, Mar 27, 2020 - (ACN Newswire) - Tai Hing Group Holdings Limited ("Tai Hing" or the "Group"; stock code: 6811), a multi-brand casual dining restaurant group with roots in Hong Kon...

The Groundbreaking Ceremony of Tongwei Solar 30GW High-perform...

CHENGDU, China, March 27, 2020 /PRNewswire-AsiaNet/ -- On March 25, the groundbreaking ceremony of Tongwei Solar Photovoltaic Industrial Base Project was held in Huaizhou New Town, Jintang C...

WPI-MANA Researchers Creating Systems That Can Think, Feel -- ...

TSUKUBA, Japan, Mar. 27, 2020 /Kyodo JBN-AsiaNet/ -- Researchers at the International Center for Materials Nanoarchitectonics (WPI-MANA), a unit of the National Institute for Materials Scien...

WCI Obtains Authorised Supervision from Financial Transactions and Reports Analysis Centre of Canada (FINTRAC)

TORONTO, Mar 27, 2020 - (ACN Newswire) - On February 3, 2020, West Capital International (WCI) obtained authorised supervision from Financial Transactions and Reports Analysis Centre of Can...

Labuan IBFC's Financial Services Community Band Together to Co...

LABUAN, Malaysia, March 27, 2020 /PRNewswire-AsiaNet/ -- Labuan International Business and Financial Centre, Labuan IBFC's financial services and intermediation community have come together ...

Huawei Mobile Services To Explore The Ultimate Potential On HU...

SHENZHEN, China, March 27, 2020 /PRNewswire-AsiaNet/ -- During the HUAWEI P40 Series Global Launch Event, Huawei announced the latest development related to the Huawei Mobile Services (HMS) ...

Huawei Unveils Servers with Intel Cascade Lake Refresh Processors

SHENZHEN, China, March 27, 2020 /PRNewswire-AsiaNet/ -- Intel has launched the Cascade Lake Refresh processor, a new member of the Cascade Lake processor family, which delivers a performance...

Mitsubishi Motors Announces Temporary Production Suspension at a Plant in Japan

TOKYO, Mar 27, 2020 - (JCN Newswire) - Mitsubishi Motors Corporation will temporarily suspend production at the following production line considering the impact on the parts supply chain du...

Fujitsu Launches Japan's First Commercial Private 5G Network

TOKYO, Mar 27, 2020 - (JCN Newswire) - Fujitsu today was granted Japan's first commercial private 5G radio station license from the Kanto Bureau of Telecommunications and will begin operati...



News Company Media Core

Content & Technology Connecting Global Audiences

More Information - Less Opinion